title: Severe liver dysfunction due to bosentan in a patient with mixed connective tissue disease.
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Nagai
authors.forename: Etsuko
authors.initials: E
authors.lastname: Okada
authors.forename: Sayaka
authors.initials: S
authors.lastname: Mihara
authors.forename: Ken
authors.initials: K
authors.lastname: Sato
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Ohi
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishikawa
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000077300:Bosentan; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D003240:Connective Tissue Diseases / Q000150:complications* / Q000473:pathology; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D016523:Foot Ulcer / Q000150:complications* / Q000473:pathology; D006801:Humans; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan